Florestan Koll

Department of Urology, School of Medicine, Rechts der Isar Medical Center, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.

View Article and Find Full Text PDF

January 2020

The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.

Authors:

Eva Lichtenegger Florestan Koll Helena Haas Klaus Mantwill Klaus-Peter Janssen Melanie Laschinger Jürgen Gschwend Katja Steiger Peter C Black Igor Moskalev Roman Nawroth Per Sonne Holm

Hum Gene Ther 2019 01 3;30(1):44-56. Epub 2018 Aug 3.

1 Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

View Article and Find Full Text PDF

January 2019

Publications by authors named "Florestan Koll"

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.

Authors:

Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.

Authors:

Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.

Authors:

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).

Authors:

The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.

Authors: